NH AG Updates on Ashland Officer-Involved Shooting Autopsy Findings

The New Hampshire Attorney General's Office released autopsy findings for Demitri Zimmer, age 24 of Laconia, NH, who died from multiple gunshot wounds during an officer-involved shooting on April 20, 2026 on Main Street in Ashland. The Office of the Chief Medical Examiner determined the manner of death was homicide, defined as the killing of one person by another. The Ashland Police Department officer who was struck by one of Mr. Zimmer's gunshots was released from the hospital on April 21. The investigation into the officer-involved use of deadly force remains ongoing, with officer identities to be disclosed once formal interviews are completed.

Peter Mancini Arrested for Unemployment Fraud

Peter Mancini, age 47, was arrested on April 22, 2026, in connection with alleged unemployment compensation fraud committed from October 2025 to February 2026. The charges allege that Mancini falsely represented that an offer of employment was rescinded, and that between January and February 2026 he and another individual acted in concert to represent he performed work searches and was available to work, while omitting that he was incarcerated. Mancini allegedly received more than $11,000 in unemployment compensation, including over $2,000 after his incarceration began on January 6, 2026. He is charged with class A felony offenses, each punishable by 7½ to 15 years in state prison.

Joint Advisory Covers Volt Typhoon, Flax Typhoon Threat Actors Using Covert Networks of Compromised Devices

A joint advisory from CISA, FBI, NSA, NCSC-UK, and eleven other international cyber agencies describes a major shift in China-nexus threat actor TTPs toward using large-scale covert networks of compromised SOHO routers, IoT devices, and smart devices instead of individually procured infrastructure. The advisory names Volt Typhoon (using the KV Botnet, mainly vulnerable Cisco and NetGear routers) and Flax Typhoon (using the Raptor Train botnet, which infected over 200,000 devices worldwide in 2024 and was controlled by Integrity Technology Group). Network defenders are advised that traditional IP blocklists are less effective against dynamic botnets with hundreds of thousands of endpoints, and that compensating controls must be applied to end-of-life devices no longer receiving security patches.

US Federal Register Vol. 91 No. 78 April 23 2026

The Office of the Federal Register published the daily Table of Contents for Vol. 91, No. 78, covering pages 21713-21936. The compilation includes entries from agencies including the Environmental Protection Agency, Agriculture Department, Commerce Department, Education Department, and Bureau of the Fiscal Service, with notices and proposed rules listed across multiple topic areas including air quality, hazardous waste, and defense production. No specific regulatory actions or compliance obligations are detailed in this index page itself.

Federal Register Vol. 91, No.78, April 23, 2026

GPO published Federal Register Volume 91, Number 78 on April 23, 2026. This entry is a volume/issue index page with no substantive document content. The Federal Register is the official daily publication for federal rules, proposed rules, and notices from U.S. government agencies. No specific rules, enforcement actions, or regulatory content are detailed in this publication index.

Federal Register Table of Contents - April 23, 2026

This is the table of contents for Federal Register Volume 91 Number 78, published on April 23, 2026. The Federal Register is the official daily publication for federal regulations, proposed rules, and notices issued by U.S. government agencies. This document serves as an index listing the contents of that day's Federal Register but does not contain the full text of any specific regulatory action.

SBA Offers Low Interest Disaster Loans to Oklahoma Drought-Affected Small Businesses

The U.S. Small Business Administration has announced that Economic Injury Disaster Loans (EIDL) of up to $2 million are now available to small businesses and private nonprofit organizations in Oklahoma, as well as parts of Arkansas, Kansas, Missouri, and Texas, following a drought declaration by the U.S. Secretary of Agriculture effective November 15, 2025. Interest rates are set at 4% for small businesses and 3.625% for private nonprofits, with terms up to 30 years; no interest accrues and no payments are due until 12 months after the first loan disbursement. The filing deadline for completed loan applications is December 10, 2026, and SBA cannot provide loans to agricultural producers, farmers, or ranchers except for small aquaculture enterprises.

Missouri Drought Relief Loans, Deadline Dec. 10

The U.S. Small Business Administration announced Economic Injury Disaster Loans (EIDLs) for small businesses and private nonprofit organizations in Missouri, Arkansas, and Illinois counties affected by drought beginning November 1, 2025. Loans of up to $2 million are available at interest rates as low as 4% for small businesses and 3.625% for nonprofits, with repayment terms up to 30 years and no interest accrual until 12 months after first disbursement. Completed applications must be submitted to SBA by December 10.

SBA Offers Up to $2M Drought Disaster Loans at 4% Interest to NM Small Businesses

The SBA announced availability of low-interest Economic Injury Disaster Loans (EIDLs) to small businesses and private nonprofit organizations in New Mexico and parts of Arizona, Colorado, Texas, and Utah affected by drought beginning November 1, 2025. Loans up to $2 million are available at 4% interest for small businesses and 3.625% for nonprofits, with terms up to 30 years and no payments due until 12 months after first disbursement. Applications must be submitted by December 10.

SBA Offers Low Interest Disaster Loans to Nevada Businesses Affected by Drought

The U.S. Small Business Administration announced Economic Injury Disaster Loans for small businesses and private nonprofits in Nevada, Arizona, Idaho, and Utah counties affected by drought beginning January 1, 2026. The declaration covers Clark, Elko, Eureka, Humboldt, Lander, Lincoln, Nye, and White Pine counties in Nevada, along with Mohave County, Arizona, and multiple counties in Idaho and Utah. Applications must be submitted by December 10, 2026. Eligible small businesses and private nonprofits may borrow up to $2 million at interest rates as low as 4% for businesses and 3.625% for nonprofits, with terms up to 30 years. The SBA sets loan amounts based on each applicant's financial condition. Agricultural producers, farmers, and ranchers are excluded except for small aquaculture enterprises. Interest and payments are deferred until 12 months after the first loan disbursement.

SBA Offers $2M Drought Disaster Loans at 4% to Utah Small Businesses and Private Nonprofits, Deadline Dec 10

The U.S. Small Business Administration announced Economic Injury Disaster Loans (EIDL) available to small businesses and private nonprofit organizations in Utah and adjacent counties in Arizona, Colorado, New Mexico, and Nevada affected by drought beginning January 1. Loans of up to $2 million carry interest rates as low as 4% for small businesses and 3.625% for private nonprofits, with repayment terms up to 30 years and no interest accrual for 12 months after the first disbursement. Applications must be submitted by December 10 via sba.gov/disaster, by phone at (800) 659-2955, or by email.

Phase 3 Ovarian Cancer Trial, Decitabine Priming Added

ClinicalTrials.gov record for NCT02159820: a Phase 3 interventional study evaluating decitabine priming in ovarian cancer treatment. The trial is registered as an active study with an overall status of 'Recruiting'. No regulatory compliance deadlines, enforcement actions, or substantive rule changes are associated with this database entry.

NK105 vs Paclitaxel, Phase 3 Breast Cancer Trial

A Phase 3 clinical trial (NCT01644890) comparing NK105 versus paclitaxel for breast cancer treatment has been registered on ClinicalTrials.gov. The trial is listed under the National Institutes of Health registry with study ID NCT01644890.

Al18F-NOTA-FAPI PET/CT Imaging for Malignant Tumors (NCT05749302)

ClinicalTrials.gov registry entry NCT05749302 for a Phase 3 interventional study evaluating Al18F-NOTA-FAPI PET/CT imaging in participants with malignant tumors. The trial is registered on ClinicalTrials.gov, operated by the National Library of Medicine under NIH, and classified as Phase 3.

EU Adopts 20th Russia Sanctions Package With 120 New Listings

EU Member States adopted the 20th package of sanctions against Russia on 23 April 2026, adding 120 new listings (33 individuals and 83 entities) for an asset freeze and travel ban. The package includes 36 Russian energy sector listings, 46 additional shadow fleet vessels (bringing the total to 632 listed vessels), a port access ban on two Russian ports (Murmansk and Tuapse) and one third-country port (Karimun Oil Terminal, Indonesia), and new trade restrictions including €365 million in export bans and €530 million in import bans. The EU activated its anti-circumvention tool for the first time against Kyrgyzstan for systematic re-export of EU machine tools and telecommunications equipment to Russia.

Phase 4 CKD Trial, NCT07547878, Active Not Recruiting

This entry documents a Phase 4 clinical trial for Chronic Kidney Disease (CKD) registered on ClinicalTrials.gov under NIH identifier NCT07547878. The trial status is listed as 'Active Not Recruiting'. Clinical trial registry entries like this one reflect compliance with federal requirements for trial registration and results reporting under NIH guidelines. No new regulatory obligations or compliance deadlines are established by this registry entry.

Pediatric Shunt Infection Prevention Trial

NIH's ClinicalTrials.gov has registered a Phase 4 clinical trial titled 'Pediatric Shunt Infection Prevention Trial' under identifier NCT07547826. This trial focuses on infection prevention measures for pediatric patients requiring cerebrospinal fluid shunts. The registry entry provides public notification of the study's existence and phase classification, enabling transparency in clinical research.

PRP vs Betamethasone Upper Trapezius Myofascial Pain Study

ClinicalTrials.gov has registered a new randomized, Phase 4 clinical trial (NCT07547605) comparing platelet-rich plasma (PRP) injections against betamethasone for the treatment of myofascial pain syndrome affecting the upper trapezius muscle. The trial's structured record includes eligibility criteria, intervention details, and outcome measures. No recruitment status, enrollment figure, or anticipated completion date was provided in the registration entry.

Phase 3 Dimethyl Fumarate Trial, Type 1 Diabetes, Adults

A Phase 3 clinical trial for Dimethyl Fumarate in adults with Type 1 Diabetes has been registered in ClinicalTrials.gov under identifier NCT07548996. The trial is categorized under Phase 3 and appears in the registry sorted by start date. This registration documents the existence and parameters of an interventional study without providing additional trial design details, enrollment numbers, or recruitment status in this entry.

TS-172 Phase 3 Hyperphosphatemia Peritoneal Dialysis Trial

A Phase 3 clinical trial evaluating TS-172 for the treatment of hyperphosphatemia in patients undergoing peritoneal dialysis has been registered on ClinicalTrials.gov. The trial is listed as NCT07548853 and is categorized under the Phase 3 filter on the registry. No recruitment status, enrollment figures, or trial endpoints are detailed in the available registration record.

TS-172 Hyperphosphatemia Hemodialysis Phase 3 Study

A Phase 3 clinical trial (NCT07548840) is registered on ClinicalTrials.gov evaluating TS-172 for treatment of hyperphosphatemia in patients undergoing hemodialysis. The study is categorized under Phase 3 interventional trials sorted by start date.

Health Canada Releases Updated Drug Product Database Data Extract

Health Canada has updated the Drug Product Database (DPD) data extract with new files as of April 1, 2026. The data extract comprises compressed UTF-8 text files totaling approximately 117 MB uncompressed, containing complete product information for approved, marketed, cancelled, and dormant products for human, veterinary, disinfectant, and radiopharmaceutical use. Users including third-party claims adjudicators, provincial formularies, and insurance companies can download the files, which include biosimilar, company, drug product, form, ingredient, packaging, pharmaceutical standard, route, schedule, status, therapeutic class, and veterinary species data.

EMA Monthly Medicines Under Evaluation Lists

The European Medicines Agency (EMA) publishes monthly updated lists of medicines for human use currently under evaluation by the Committee for Medicinal Products for Human Use (CHMP) for marketing authorisation in the EU via the centralised procedure. The April 2026 list of applications for new human medicines is available as an Excel file (EMA/80934/2026, 104.78 KB), first published on 14 April 2026, alongside extension applications and Type II variation procedure lists from February-March 2026.

DOJ Reschedules FDA-Approved Marijuana Products to Schedule III Under CSA

Acting Attorney General Todd Blanche issued an order immediately placing FDA-approved products containing marijuana and medicinal marijuana products subject to a qualifying state-issued license in Schedule III of the Controlled Substances Act. The action is taken under authority to reschedule drugs to carry out U.S. obligations under the Single Convention on Narcotic Drugs, and follows President Trump's December 18, 2025 Executive Order on Increasing Medical Marijuana and Cannabidiol Research. Separately, DEA is withdrawing the prior notice of hearing published under the prior administration and will hold a new administrative hearing beginning June 29, 2026 to consider the broader rescheduling of marijuana from Schedule I to Schedule III.

NEC Corporation Work Management Device Tracks Login, Operation History, Calculates Working Hours

USPTO granted US Patent 12,608,683 B2 to NEC Corporation on April 21, 2026, covering a work management device that tracks login and terminal operation history. The system specifies non-operation periods from the operation history and calculates working hours including those non-operation periods. The patent contains 15 claims.

Palantir Granted US12608254B2 for Data Validation Systems

Palantir Technologies Inc. has been granted US Patent 12608254B2 for systems and methods of validating data, with the patent effective April 21, 2026. The patent application (17573580) was filed on January 11, 2022, and lists David Lisuk, Guodong Xu, Luis Voloch, and Matthew Elkherj as inventors, with 19 claims total.

Maplebear Inc. Patent for Warehouse Item Location Inference, Granted Apr 21

The USPTO granted Patent US12608679B2 to Maplebear Inc. on April 21, 2026. The patent covers a method for optimizing order fulfillment in a warehouse by receiving an item catalog with location data from an inventory system, obtaining a taxonomy organizing items hierarchically by attributes, and inferring missing item locations by identifying alternative items with shared attributes. The system also optimizes a picking sequence to minimize travel distance and transmits the sequence to a shopper's device for fulfillment. The patent names six inventors: Benjamin Knight, Darren Johnson, Daniel Haugh, Saumitra Maheshwari, Qi Xi, and Conor Woods.

Large Language Model Integration for Scenario Generation in Risk Management Platform

USPTO granted patent US12608672B2 to Fusion Risk Management, Inc. for a system integrating large language models into scenario generation for business continuity and risk management platforms. The patent covers establishing communicative coupling between a business continuity management user interface and a selected LLM, querying scenario databases with adverse event vectors, tuning LLM prompts with organization-specific data, and generating plausible scenarios for simulation engines. The patent names Robert Davis DeRodes, Zachary Keller, and James Post as inventors, with a filing date of October 11, 2023 and 12 claims.

SAP SE Patent US12608678B2, Integration Microservice, 21st Apr

SAP SE has been granted US Patent US12608678B2 titled 'Integration of enterprise software applications to support logistical analysis.' The patent discloses a method involving an integration microservice receiving fetch requests for tracking data, determining tenant capacity, and distributing jobs to data load microservice instances based on capacity matching. The 20-claim patent was filed on December 20, 2022, with inventors Dexian Li, Yun Jin, Zichao Song, and Hanmei Zhang.

FourKites Geofence Tracking Patent, 17 Claims, Apr 21

The USPTO granted US Patent 12608676B2 to FourKites, Inc. on April 21, 2026. The patent covers systems, methods, and computer-readable medium for tracking shipment services using geofences at shipping facilities, incorporating location data from mobile computing devices and other sources to estimate milestone events. The patent contains 17 claims classified under CPC G06Q 10/0833.

Asana Granted Patent for User-Generated GUI Collaboration

USPTO granted Patent US12608681B2 to Asana, Inc. on April 21, 2026, covering systems and methods for providing user-generated graphical user interfaces within a collaboration environment. The patent names inventors Melissa Christina Adams and John Lamar Whelchel and contains 20 claims under CPC classifications including G06Q 10/103 and G06F 3/0486.

Zimmer Shoulder Stem, Modular Sensor, EP4478943A1

European Patent Office published patent application EP4478943A1 titled 'Shoulder Stem with Modular Sensor' filed by Zimmer, Inc. The application covers a shoulder stem prosthetic device incorporating modular sensor technology. Named inventors include MILLER, Kevin, BOHNENKAMPER, Kyle A., GOSON, Kristoff, and PARISI, Raymond C. The patent is classified under A61B 5/00 (measuring for diagnostic purposes), A61F 2/40 (shoulder prostheses), and related orthopedic device classifications. Publication date is April 15, 2026.

Gynecological Prosthetic with Anchor Members and Expandable Connecting Links

The European Patent Office published patent application EP4518819A1 for a gynecological prosthetic device featuring anchor members and expandable connecting links, along with a method for custom-designing such prosthetics. The patent is assigned to FemTherapeutics Inc. with nine named inventors. The application covers multiple designated contracting states across Europe including Germany, France, the United Kingdom, Italy, Spain, and others.

Self Fixing Mesh Endoprosthesis Based on Titanium Thread and Bioresorbable Polymers

The European Patent Office published patent application EP4309689A2 on April 15, 2026, covering a self-fixing mesh endoprosthesis composed of titanium thread and bioresorbable polymers. The applicant is Titanium Textiles AG, with four named inventors: Kazantsev, Yusupov, Alehin, and Zavaruev. The patent is classified under A61F 2/00 (prosthetics), A61L 27/06, A61L 31/02, and A61L 31/10 (materials for medical devices), and designates 35 contracting states including all major EU jurisdictions.

MAKO Surgical Corp Prosthetic Positioning System, Apr 15

The European Patent Office published patent application EP4324421A2 titled 'Surgical System for Positioning Prosthetic Component and/or for Constraining Movement of Surgical Tool,' filed by MAKO Surgical Corp. The application names five inventors: HAGAG, Benny; KANK, Hyosig; MOZES, Alon; ODERMATT, Daniel; and SCHMITZ, Brian D. The system covers robotic-assisted surgical tools for prosthetic component positioning, classified under A61B 34/30, A61B 17/16, and A61F 2/34. The patent application is designated across 31 European states including all EU member states, Switzerland, Norway, and Turkey. MAKO Surgical Corp, a Stryker subsidiary, specializes in robotic-arm assisted surgery primarily for orthopedics, and this published application indicates an active IP filing phase before potential grant.

Edwards Lifesciences Prosthetic Heart Valve Patent EP4299037A2

The EPO published European patent application EP4299037A2 for Edwards Lifesciences Corporation's prosthetic heart valve and delivery apparatus (A61F 2/24) on April 15, 2026. The patent designates 39 contracting states spanning Albania to Turkey (AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR). Fourteen inventors are listed, including Levi Tamir S., Bukin Michael, Nir Noam, and others.

Cardiac Aorto-Mitral Prosthesis EP4360592A1

The European Patent Office published patent application EP4360592A1 for a cardiac aorto-mitral prosthesis invented by Andrasi, Terezia. The invention, classified under A61F 2/24 and A61F 2/00, relates to a cardiac valve prosthesis designed for the aorto-mitral region of the human heart. The patent designation extends across 34 European states including DE, FR, GB, IT, ES, NL, BE, CH, and others.

Warsaw Orthopedic Expands Interbody Implant Patent, EP4358902A1

The European Patent Office published application EP4358902A1 on April 15, 2026, covering an expandable interbody implant and corresponding surgical tool. Warsaw Orthopedic, Inc. is listed as the applicant, with Stanley Hayes, Kyle Loke, Robert Barfield, Charles Protopsaltis, and Dimitri K. as named inventors. The patent is classified under A61F 2/44 and related orthopedic surgical device categories, with designation extending to all European Patent Convention contracting states.

Medtronic Prosthetic Valve Device Resistant to Backfolding and Buckling, EP4098225A1

The European Patent Office has published patent application EP4098225A1 for Medtronic, Inc., covering a prosthetic valve device designed to resist backfolding and buckling. The patent, classified under A61F 2/24 and A61F 2/915, names nine inventors including Timothy Kelley, Victoria Tien, and Geoffrey Orth. The application received A1 publication status with designation extending across 31 European states including Germany, France, the United Kingdom, Italy, and Spain.

Prosthetic Heart Valve Leaflet Assembly Patent, Edwards Lifesciences

European Patent Office published EP4356876A2 on April 15, 2026, granting Edwards Lifesciences Corporation a patent for prosthetic heart valve leaflet assemblies and methods of assembling. The patent application EP4356876 was filed by inventors Nir Noam, Bukin Michael, and Sherman Elena, covering innovations in prosthetic heart valve technology. Designated states span all 31 European Patent Convention member states including Germany, France, the United Kingdom, Italy, Spain, and the Netherlands.

Aesculap AG Patella Trial Implant System With Drilling Guide Tool

The European Patent Office published patent application EP4563123A1 for Aesculap AG on April 15, 2026. The application covers a system comprising a patella trial implant and a drilling guide tool for orthopedic surgical procedures, with inventor Eliott Snauwaert named. The patent application has been published with IPC classifications A61F 2/38, A61B 17/16, A61B 17/17, A61F 2/46, and A61F 2/30, designating 38 European states including Germany, France, the United Kingdom, Italy, and Spain.

Carlsmed Patient-Specific Spinal Implant Patent EP4362858A1 Published

The European Patent Office published European Patent EP4362858A1 on 15 April 2026. The patent lists Carlsmed, Inc. as applicant and covers patient-specific adjustment systems for spinal implants, including associated methods and workflows. The A1 publication indicates inclusion of the European search report.

Cook Medical Stent Graft Patent EP4088686A1

The European Patent Office published patent application EP4088686A1 titled 'Stent Graft Graft and Method of Forming an Endoluminal Medical Device' filed by Cook Medical Technologies LLC. The patent names inventors King, Bradway, Kratzberg, and Wilger, with international protection designated across 27 European states including DE, FR, GB, IT, and NL.

Microsoft Pose Prediction Patent, Articulated Objects, Published Apr 15 2026

The EPO published patent application EP4487193A1 for Microsoft Technology Licensing LLC covering pose prediction systems for articulated objects using machine learning. The invention involves classifying input data using neural networks to predict object configurations. The patent application names four inventors: Ali Akbarian, Mohammad Sadegh, Pashmina Jonathan Cameron, Andrew William Fitzgibbon, and Thomas Joseph Cashman.

Google LLC European Patent - Distributed Computing Pipeline, EP4293570A2

The European Patent Office published European Patent Application EP4293570A2 for Google LLC, titled 'Distributed Computing Pipeline Processing', granted on April 15, 2026. The patent covers IPC classifications G06F 9/48, G06F 9/50, G06N 3/02, G06N 3/006, G06N 3/045, and G06N 3/08, spanning distributed computing resource management, neural networks, and machine learning pipeline architectures. Designated states include all EU member states plus other European Economic Area countries.

Google EP Patent, Memory-Augmented Self-Attention Neural Networks, Apr 15

The European Patent Office published patent application EP4396729A1 titled 'USING MEMORY TO AUGMENT SELF-ATTENTION IN NEURAL NETWORKS' on April 15, 2026. Google LLC is listed as the applicant with Christian Szegedy, DeLesley Hutchins, Markus Rabe, and Yuhuai Wu as inventors. The patent covers memory-augmented neural network architectures classified under IPC G06N (computer models based on biological or biological-inspired methods).

Microsoft Masked Autoencoder Patent for Image Inpainting

The European Patent Office published patent application EP4526798A1 filed by Microsoft Technology Licensing, LLC, titled 'Training Masked Autoencoders for Image Inpainting,' with inventors including Chen Dongdong, Bao Jianmin, Zhang Ting, Yuan Lu, Chen Dong, Wen Fang, and Dong Xiaoyi. The patent application, covering AI-based image inpainting techniques under IPC classifications G06N and G06T, was published on April 15, 2026 and designates 38 European member states including Germany, France, the United Kingdom, Italy, Spain, and the Netherlands.

Neural Radiation Field Method Constructs 3D Pedestrian Datasets

The European Patent Office published patent application EP2023093186A1 on April 15, 2026, filed by Zhejiang Lab, covering a neural radiation field-based method and apparatus for constructing pedestrian re-identification three-dimensional datasets. The application relates to computer vision techniques under IPC classifications G06N 3/04 and G06N 3/08. Designated states cover all major European Patent Convention member states including DE, FR, GB, IT, NL, ES, and 26 others.